Fundz

Enzyre Closes Series A Financing Round Of Eur 12M To Advance Pioneering Diagnostic Technology Platform For Hemophilia Patients

PRIVATENov 02, 2022

Round Type

Series A

NijmegenBiotechnologyHealth CareMedical

Description

Enzyre, which is developing breakthrough ambulant diagnostic technology for blood coagulation testing, today announced that it has successfully raised EUR 12 million in a Series A financing led by new investor, Oost NL, with participation from i&i Biotech Fund, Demcon Investment as technology partner and existing investors, Takeda Ventures and Novalis Biotech. Part of the funding is an Innovation Credit from the Dutch Government.

Quick answer

Enzyre raised an undisclosed amount in a Series A round, dated November 2, 2022. Enzyre is based in Nijmegen, Gelderland, Netherlands.

How much did Enzyre raise?
Enzyre raised an undisclosed amount in a Series A round on November 2, 2022.
What does Enzyre do?
Enzyre is a spin-out from Radboud University Medical Center in The Netherlands founded by Waander van Heerde and Guido Maertens.
Where is Enzyre based and how big is it?
Enzyre is based in Nijmegen, Gelderland, Netherlands.

Source: Fundz verified event record.

Who else raised in Medical and Biotechnology around the same time

Companies in the same sectors as Enzyre that raised within 45 days of this round, from Fundz verified event records.

  • Fountain Life raised $15M on December 15, 2022.
  • KeyOps raised $4M (Seed) on December 13, 2022.
  • Ubie raised an undisclosed amount (Series C) on December 8, 2022.
  • TRiCares raised $54M (Series C) on December 6, 2022.
  • Nox Health raised an undisclosed amount (Corporate Round) on November 30, 2022.
  • Medical Informatics raised $27M (Funding Round) on November 29, 2022.

Who to call at Enzyre, and when

A new round usually means Enzyre is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Enzyre raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Enzyre, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Enzyre. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Enzyre

Location

Nijmegen, Gelderland, Netherlands

About

Enzyre is a spin-out from Radboud University Medical Center in The Netherlands founded by Waander van Heerde and Guido Maertens. The Company aims to develop a diagnostic device to provide patients with the flexibility to assess their coagulation status regardless of where they are. Enzyre's platform requires a small volume of blood to measure up to sixteen reactions simultaneously with high sensitivity and specificity without any laboratory infrastructure, at home, on the road or in a critical care setting. This offers enormous benefits to patients: avoid crisis situations driven by changes in coagulation status, provide ease of mind for patients, empower patients to optimize treatment themselves, be a quick turnaround tool in the clinical setting, reduce GP consultation visits and, as a personalized diagnostic tool, offer great support in a telemedicine setting.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Enzyre raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Enzyre's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Enzyre raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.